Nathan Budischak

Nathan Budischak advises life sciences clients on pricing, contracting, market access, and gross-to-net strategies across commercial, government, and institutional payers.

Prior to joining Avalere, Nathan was an associate director of market access at Jazz Pharmaceuticals, where he built strategy and analytics around product pricing, payer/PBM contracting, competitive bid cycles, contract pull-through and ROI, new indication launch, authorized generic entry, GTN forecasting, and patient support program/field reimbursement team effectiveness.  Prior to that, Nathan was a senior consultant at IQVIA, where he led commercial insights and strategy consulting for a top 10 pharma client.

Nathan holds a BSE in bioengineering and MSE in nanotechnology from the University of Pennsylvania.